Bronchogen vs Epithalon

Overview

Bronchogen and Epithalon are both studied in the peptide research space.

Bronchogen: A synthetic tetrapeptide (Ala-Glu-Asp-Leu) developed by Russian scientist Vladimir Khavinson for bronchial and respiratory tissue support.

Epithalon: A synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed by Russian scientist Vladimir Khavinson, claimed to activate telomerase and extend lifespan.

Evidence Comparison

Aspect	Bronchogen	Epithalon
Evidence Level	Low	Low
Human Studies	2	5
Preclinical Studies	8	15
Total Sources	12	28

Key Differences

Aspect	Bronchogen	Epithalon
Category	Other	Longevity
Evidence Strength	Low	Low
Total Sources	12	28
Human Studies	2	5

Summary

• Bronchogen: Low evidence with 12 total sources (2 human)
• Epithalon: Low evidence with 28 total sources (5 human)

---

This comparison is for educational purposes only and is not medical advice. Consult a healthcare professional before making any decisions about peptide use.